Clinical Outcomes in Men With Prostate Cancer Who Selected Active Surveillance Using a Clinical Cell-Cycle Risk Score

Personalized Medicine - United Kingdom
doi 10.2217/pme-2019-0084
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Future Medicine Ltd

Related search

Why Men With a Low-Risk Prostate Cancer Select and Stay on Active Surveillance: A Qualitative Study

PLoS ONE
Multidisciplinary
2019English

Active Surveillance in Prostate Cancer

Üroonkoloji Bülteni
2017English

Genomic Scores Are Independent of Disease Volume in Men With Favorable Risk Prostate Cancer: Implications for Choosing Men for Active Surveillance

Journal of Urology
Urology
2018English

Active Surveillance in Intermediate Risk Prostate Cancer: Is It Safe?

International braz j urol : official journal of the Brazilian Society of Urology
MedicineUrology
2016English

Impact of Metformin on Clinical Outcomes Among Men With Prostate Cancer: A Systematic Review and Meta-Analysis

Prostate Cancer and Prostatic Diseases
Cancer ResearchOncologyUrology
2015English

Brachytherapy in Prostate Cancer: Techniques and Clinical Outcomes

Trends in Urology & Men's Health
2018English

Active Surveillance for Prostate Cancer

International Journal of Urology
Urology
2015English

Small Cell Prostate Cancer: A Clinical Case

Onkourologiya
OncologyRadiologyUrologyNuclear MedicineNephrologyImagingSurgery
2019English

SS8 Active Surveillance for Men With Newly Diagnosed Prostate Cancer : Critical Role of Pathology

Japanese Journal of Urology
Urology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy